Anders Ljunggren

City:

Molndal

Country:

Sweden

Published Applications:

Last publication date:

2018-03-22

Top Assignees for applications by Anders Ljunggren

The entities that hold a legal rights for patent applications filed by inventor Ljunggren Anders:

AstraZeneca AB 2 Sodertalje, Sweden
Aventis Pharma Deutschland GmbH 1 Frankfurt am Main, Germany

Recent patent applications by Ljunggren Anders

Anders Ljunggren from Molndal, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-03-22

US20180078529A1

Human necessities

ANGIOTENSIN II RECEPTOR AGONIST FOR TREATING PULMONARY FIBROSIS

#2 | 2013-11-28

US20130317047A1

Human necessities

PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE

#3 | 2011-10-27

US20110263619A1

Human necessities

PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE

#4 | 2010-10-21

US20100267798A1

Human necessities

PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE

#5 | 2009-11-12

US20090281083A1

Human necessities

Combination Product

#6 | 2009-10-15

US20090258919A1

Human necessities

Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure

#7 | 2008-05-29

US20080125472A1

Human necessities

PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE

#8 | 2006-08-31

US20060194868A1

Human necessities

Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failure

#9 | 2006-08-31

US20060194856A1

Human necessities

Use of atii antagonist for the treatment or prevention of metabolic syndrome

InventorID:

549136 ⎘